Polyclonal antibody with avidity to ROS used for determination for ROS in plasma
IgG fractions were isolated and purified through avidity chromatography on protein A column

Solid phase extraction (SPE)

Polyclonal antibody with avidity to ROS used for determination for ROS in plasma

05 Jul, 2011

Published over 15 years ago. See the latest and most current information on Solid phase extraction (SPE).

The results of a study to find the determination of ROS in plasma have been revealed.

Published in the Chemistry Central Journal 2011, the experiment used a polyclonal antibody with high avidity and to ROS.

It was then used in the development of highly sensitive ELISA for determination of ROS in plasma.

A number of eight-week old New Zealand white rabbits were immunised with the ROS-KLH conjugate and were then monitored by direct ELISA using ROS-BSA immobilised onto microwell plates as a solid phase.

Sera was collected from the rabbit with the highest antibody titer and avidity to ROS and the IgG fraction was isolated and purified through avidity chromatography on protein A column.

The conclusion revealed that the purified antibody showed high avidity to ROS; IC50= 0.4ng/ml, with the concentration of ROS in the sample justified by its capacity to stop the binding of the anti-ROS antibody to the immobilised ROS-BSA.

Rosuvastatin is often used to treat high cholesterol issues, while also plays a part in limiting cardiovascular problems. 

Latest News

Explore Our Other Sites

Labmate Online
Smart temperature control. Designed for the future.
Explore more Arrow
Envirotech Online
Vehicle-based methane detection system passes German suitability test
Explore more Arrow
Pollution Solutions Online
Large-scale liquefied biogas bunkering to become possible in the Port of Gothenburg in 2027
Explore more Arrow
Petro Online
PFAS reference standard combines ten analytes to support trace-level calibration
Explore more Arrow